- Home
- BOXL vs RDHL Comparison
BOXL vs RDHL Comparison
Compare BOXL & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOXL
- RDHL
- Stock Information
- Founded
- BOXL 1985
- RDHL 2009
- Country
- BOXL United States
- RDHL Israel
- Employees
- BOXL N/A
- RDHL N/A
- Industry
- BOXL Telecommunications Equipment
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- BOXL Telecommunications
- RDHL Health Care
- Exchange
- BOXL Nasdaq
- RDHL Nasdaq
- Market Cap
- BOXL 3.9M
- RDHL 3.8M
- IPO Year
- BOXL 2017
- RDHL N/A
- Fundamental
- Price
- BOXL $1.83
- RDHL $2.02
- Analyst Decision
- BOXL Buy
- RDHL
- Analyst Count
- BOXL 3
- RDHL 0
- Target Price
- BOXL $5.00
- RDHL N/A
- AVG Volume (30 Days)
- BOXL 16.5K
- RDHL 19.8K
- Earning Date
- BOXL 08-06-2025
- RDHL 04-10-2025
- Dividend Yield
- BOXL N/A
- RDHL N/A
- EPS Growth
- BOXL N/A
- RDHL N/A
- EPS
- BOXL N/A
- RDHL N/A
- Revenue
- BOXL $121,223,000.00
- RDHL $8,042,999.00
- Revenue This Year
- BOXL N/A
- RDHL $381.91
- Revenue Next Year
- BOXL N/A
- RDHL N/A
- P/E Ratio
- BOXL N/A
- RDHL N/A
- Revenue Growth
- BOXL N/A
- RDHL 23.17
- 52 Week Low
- BOXL $1.06
- RDHL $1.71
- 52 Week High
- BOXL $10.65
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- BOXL 51.44
- RDHL 56.71
- Support Level
- BOXL $1.72
- RDHL $1.75
- Resistance Level
- BOXL $1.89
- RDHL $2.08
- Average True Range (ATR)
- BOXL 0.13
- RDHL 0.10
- MACD
- BOXL -0.01
- RDHL 0.02
- Stochastic Oscillator
- BOXL 41.51
- RDHL 82.42
About BOXL Boxlight Corporation
Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions including flat panels, LED video walls, and digital signage. The company also distributes science, technology, engineering, and math (or STEM) products, including 3D printing and robotics solutions and a portable science lab.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.